Ferroptosis becomes immunogenic: implications for anticancer treatments
Ferroptosis is an iron-dependent form of non-apoptotic cell death that has recently been attributed with antitumor immune effects. Thus, early ferroptotic cells underwent immunogenic cell death that was accompanied by the emission of damage-associated molecular patterns (DAMPs) and triggered dendrit...
Main Authors: | Daolin Tang, Oliver Kepp, Guido Kroemer |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1862949 |
Similar Items
-
Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
by: Abhishek D. Garg, et al.
Published: (2017-12-01) -
Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
by: Oliver Kepp, et al.
Published: (2020-01-01) -
Dendritic Cells in Anticancer Vaccination: Rationale for Ex Vivo Loading or In Vivo Targeting
by: Alexey V. Baldin, et al.
Published: (2020-03-01) -
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
by: Rong Tang, et al.
Published: (2020-08-01) -
Between biology and medicine: perspectives on the use of dendritic cells in anticancer therapy
by: Agnieszka Szczygieł, et al.
Published: (2017-11-01)